Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Right to Left Cardiac Shunt Detection
A With-in Subject, Controlled Study to Determine the Sensitivity and Specificity of the Cardiox Flow Detection System for the Detection of Right-to-Left Cardiac Shunts Compared to Transesophageal Echocardiography and Transcranial Doppler Ultrasound
Status: Enrolling
Updated:  11/10/2015
UCLA Medical Center
mi
from
Los Angeles, CA
Right to Left Cardiac Shunt Detection
A With-in Subject, Controlled Study to Determine the Sensitivity and Specificity of the Cardiox Flow Detection System for the Detection of Right-to-Left Cardiac Shunts Compared to Transesophageal Echocardiography and Transcranial Doppler Ultrasound
Status: Enrolling
Updated: 11/10/2015
UCLA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Right to Left Cardiac Shunt Detection
A With-in Subject, Controlled Study to Determine the Sensitivity and Specificity of the Cardiox Flow Detection System for the Detection of Right-to-Left Cardiac Shunts Compared to Transesophageal Echocardiography and Transcranial Doppler Ultrasound
Status: Enrolling
Updated:  11/10/2015
Rush University Medical Center
mi
from
Chicago, IL
Right to Left Cardiac Shunt Detection
A With-in Subject, Controlled Study to Determine the Sensitivity and Specificity of the Cardiox Flow Detection System for the Detection of Right-to-Left Cardiac Shunts Compared to Transesophageal Echocardiography and Transcranial Doppler Ultrasound
Status: Enrolling
Updated: 11/10/2015
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Right to Left Cardiac Shunt Detection
A With-in Subject, Controlled Study to Determine the Sensitivity and Specificity of the Cardiox Flow Detection System for the Detection of Right-to-Left Cardiac Shunts Compared to Transesophageal Echocardiography and Transcranial Doppler Ultrasound
Status: Enrolling
Updated:  11/10/2015
Tufts Medical Center
mi
from
Boston, MA
Right to Left Cardiac Shunt Detection
A With-in Subject, Controlled Study to Determine the Sensitivity and Specificity of the Cardiox Flow Detection System for the Detection of Right-to-Left Cardiac Shunts Compared to Transesophageal Echocardiography and Transcranial Doppler Ultrasound
Status: Enrolling
Updated: 11/10/2015
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Right to Left Cardiac Shunt Detection
A With-in Subject, Controlled Study to Determine the Sensitivity and Specificity of the Cardiox Flow Detection System for the Detection of Right-to-Left Cardiac Shunts Compared to Transesophageal Echocardiography and Transcranial Doppler Ultrasound
Status: Enrolling
Updated:  11/10/2015
Columbia University Medical Center
mi
from
New York, NY
Right to Left Cardiac Shunt Detection
A With-in Subject, Controlled Study to Determine the Sensitivity and Specificity of the Cardiox Flow Detection System for the Detection of Right-to-Left Cardiac Shunts Compared to Transesophageal Echocardiography and Transcranial Doppler Ultrasound
Status: Enrolling
Updated: 11/10/2015
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Right to Left Cardiac Shunt Detection
A With-in Subject, Controlled Study to Determine the Sensitivity and Specificity of the Cardiox Flow Detection System for the Detection of Right-to-Left Cardiac Shunts Compared to Transesophageal Echocardiography and Transcranial Doppler Ultrasound
Status: Enrolling
Updated:  11/10/2015
Methodist DeBakey Heart & Vascular Center
mi
from
Houston, TX
Right to Left Cardiac Shunt Detection
A With-in Subject, Controlled Study to Determine the Sensitivity and Specificity of the Cardiox Flow Detection System for the Detection of Right-to-Left Cardiac Shunts Compared to Transesophageal Echocardiography and Transcranial Doppler Ultrasound
Status: Enrolling
Updated: 11/10/2015
Methodist DeBakey Heart & Vascular Center
mi
from
Houston, TX
Click here to add this to my saved trials
Right to Left Cardiac Shunt Detection
A With-in Subject, Controlled Study to Determine the Sensitivity and Specificity of the Cardiox Flow Detection System for the Detection of Right-to-Left Cardiac Shunts Compared to Transesophageal Echocardiography and Transcranial Doppler Ultrasound
Status: Enrolling
Updated:  11/10/2015
Swedish Medical Center
mi
from
Seattle, WA
Right to Left Cardiac Shunt Detection
A With-in Subject, Controlled Study to Determine the Sensitivity and Specificity of the Cardiox Flow Detection System for the Detection of Right-to-Left Cardiac Shunts Compared to Transesophageal Echocardiography and Transcranial Doppler Ultrasound
Status: Enrolling
Updated: 11/10/2015
Swedish Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Right to Left Cardiac Shunt Detection
A With-in Subject, Controlled Study to Determine the Sensitivity and Specificity of the Cardiox Flow Detection System for the Detection of Right-to-Left Cardiac Shunts Compared to Transesophageal Echocardiography and Transcranial Doppler Ultrasound
Status: Enrolling
Updated:  11/10/2015
University of Colorado
mi
from
Aurora, CO
Right to Left Cardiac Shunt Detection
A With-in Subject, Controlled Study to Determine the Sensitivity and Specificity of the Cardiox Flow Detection System for the Detection of Right-to-Left Cardiac Shunts Compared to Transesophageal Echocardiography and Transcranial Doppler Ultrasound
Status: Enrolling
Updated: 11/10/2015
University of Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Acute Effects of Beet Juice Consumption on Exercise Capacity in Heart Failure
Acute Effects of Beet Juice Consumption on Exercise Capacity in Heart Failure
Status: Enrolling
Updated:  11/10/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Acute Effects of Beet Juice Consumption on Exercise Capacity in Heart Failure
Acute Effects of Beet Juice Consumption on Exercise Capacity in Heart Failure
Status: Enrolling
Updated: 11/10/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Pharmacodynamic Evaluation of Switching From Prasugrel to Ticagrelor
Pharmacodynamic Evaluation of Switching From Prasugrel to Ticagrelor: The SWAP (SWitching Anti Platelet)-3 Study
Status: Enrolling
Updated:  11/10/2015
University of Florida
mi
from
Jacksonville, FL
Pharmacodynamic Evaluation of Switching From Prasugrel to Ticagrelor
Pharmacodynamic Evaluation of Switching From Prasugrel to Ticagrelor: The SWAP (SWitching Anti Platelet)-3 Study
Status: Enrolling
Updated: 11/10/2015
University of Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
In Vitro Pharmacodynamic Effects of Cangrelor in Ticagrelor Treated Patients
In Vitro Pharmacodynamic Effects of Cangrelor on Platelet P2Y12 Receptor Mediated Signaling in Ticagrelor Treated Patients
Status: Enrolling
Updated:  11/10/2015
Dominick Angiolillo
mi
from
Jacksonville, FL
In Vitro Pharmacodynamic Effects of Cangrelor in Ticagrelor Treated Patients
In Vitro Pharmacodynamic Effects of Cangrelor on Platelet P2Y12 Receptor Mediated Signaling in Ticagrelor Treated Patients
Status: Enrolling
Updated: 11/10/2015
Dominick Angiolillo
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Histamine Glutamate Antagonism in Stroke
Glutaminergic and Histaminergic Pathway Modulation in Acute Ischemic Stroke as an Effective Neuroprotection Strategy.
Status: Enrolling
Updated:  11/10/2015
Shands Hospital at the University of Florida
mi
from
Gainesville, FL
Histamine Glutamate Antagonism in Stroke
Glutaminergic and Histaminergic Pathway Modulation in Acute Ischemic Stroke as an Effective Neuroprotection Strategy.
Status: Enrolling
Updated: 11/10/2015
Shands Hospital at the University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Evaluation of Myocardial Effects of Bendavia for Reducing Reperfusion Injury in Patients With Acute Coronary Events
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Tolerability and Efficacy of Intravenous Bendavia (MTP-131) on Reperfusion Injury in Patients Treated With Standard Therapy Including Primary PCI and Stenting for ST-segment Elevation Myocardial Infarction
Status: Enrolling
Updated:  11/11/2015
Advanced Medical Research Center
mi
from
Port Orange, FL
Evaluation of Myocardial Effects of Bendavia for Reducing Reperfusion Injury in Patients With Acute Coronary Events
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Tolerability and Efficacy of Intravenous Bendavia (MTP-131) on Reperfusion Injury in Patients Treated With Standard Therapy Including Primary PCI and Stenting for ST-segment Elevation Myocardial Infarction
Status: Enrolling
Updated: 11/11/2015
Advanced Medical Research Center
mi
from
Port Orange, FL
Click here to add this to my saved trials
Evaluation of Myocardial Effects of Bendavia for Reducing Reperfusion Injury in Patients With Acute Coronary Events
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Tolerability and Efficacy of Intravenous Bendavia (MTP-131) on Reperfusion Injury in Patients Treated With Standard Therapy Including Primary PCI and Stenting for ST-segment Elevation Myocardial Infarction
Status: Enrolling
Updated:  11/11/2015
Henry Ford Hospital
mi
from
Detroit, MI
Evaluation of Myocardial Effects of Bendavia for Reducing Reperfusion Injury in Patients With Acute Coronary Events
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Tolerability and Efficacy of Intravenous Bendavia (MTP-131) on Reperfusion Injury in Patients Treated With Standard Therapy Including Primary PCI and Stenting for ST-segment Elevation Myocardial Infarction
Status: Enrolling
Updated: 11/11/2015
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Evaluation of Myocardial Effects of Bendavia for Reducing Reperfusion Injury in Patients With Acute Coronary Events
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Tolerability and Efficacy of Intravenous Bendavia (MTP-131) on Reperfusion Injury in Patients Treated With Standard Therapy Including Primary PCI and Stenting for ST-segment Elevation Myocardial Infarction
Status: Enrolling
Updated:  11/11/2015
Creighton Cardiac Center
mi
from
Omaha, NE
Evaluation of Myocardial Effects of Bendavia for Reducing Reperfusion Injury in Patients With Acute Coronary Events
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Tolerability and Efficacy of Intravenous Bendavia (MTP-131) on Reperfusion Injury in Patients Treated With Standard Therapy Including Primary PCI and Stenting for ST-segment Elevation Myocardial Infarction
Status: Enrolling
Updated: 11/11/2015
Creighton Cardiac Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Evaluation of Myocardial Effects of Bendavia for Reducing Reperfusion Injury in Patients With Acute Coronary Events
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Tolerability and Efficacy of Intravenous Bendavia (MTP-131) on Reperfusion Injury in Patients Treated With Standard Therapy Including Primary PCI and Stenting for ST-segment Elevation Myocardial Infarction
Status: Enrolling
Updated:  11/11/2015
Universitätsmedizin Berlin, Charité Campus Benjamin Franklin
mi
from
Berlin,
Evaluation of Myocardial Effects of Bendavia for Reducing Reperfusion Injury in Patients With Acute Coronary Events
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Tolerability and Efficacy of Intravenous Bendavia (MTP-131) on Reperfusion Injury in Patients Treated With Standard Therapy Including Primary PCI and Stenting for ST-segment Elevation Myocardial Infarction
Status: Enrolling
Updated: 11/11/2015
Universitätsmedizin Berlin, Charité Campus Benjamin Franklin
mi
from
Berlin,
Click here to add this to my saved trials
Exercise, Heart Failure, and Type 2 Diabetes
Vascular and Metabolic Responses to Exercise Training in Heart Failure With or Without Type 2 Diabetes
Status: Enrolling
Updated:  11/11/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Exercise, Heart Failure, and Type 2 Diabetes
Vascular and Metabolic Responses to Exercise Training in Heart Failure With or Without Type 2 Diabetes
Status: Enrolling
Updated: 11/11/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Yoga and Rate and Duration of Inappropriate Sinus Tachycardia (IST) Episodes
The Effect of Yoga on Arrhythmia Burden and Quality of Life in Patients With Inappropriate Sinus Tachycardia
Status: Enrolling
Updated:  11/13/2015
University of Kansas Medical Center
mi
from
Kansas City, KA
Yoga and Rate and Duration of Inappropriate Sinus Tachycardia (IST) Episodes
The Effect of Yoga on Arrhythmia Burden and Quality of Life in Patients With Inappropriate Sinus Tachycardia
Status: Enrolling
Updated: 11/13/2015
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
RF Lesion Monitoring With 8mm IntellaTip MiFi XP
Radiofrequency Ablation Lesion Monitoring Using Imbedded Micro-Electrodes Versus Standard Bipolar Electrograms
Status: Enrolling
Updated:  11/14/2015
Emory University Hospital
mi
from
Atlanta, GA
RF Lesion Monitoring With 8mm IntellaTip MiFi XP
Radiofrequency Ablation Lesion Monitoring Using Imbedded Micro-Electrodes Versus Standard Bipolar Electrograms
Status: Enrolling
Updated: 11/14/2015
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
B-Receptor Signaling in Cardiomyopathy
B-Receptor Signaling in Cardiomyopathy
Status: Enrolling
Updated:  11/16/2015
Stanford University School of Medicine
mi
from
Stanford, CA
B-Receptor Signaling in Cardiomyopathy
B-Receptor Signaling in Cardiomyopathy
Status: Enrolling
Updated: 11/16/2015
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Single Dose Enteral Tranexamic Acid in Critically Ill Patients
Single Dose Enteral Tranexamic Acid for the Reduction of Morbidity in Hospitalized Critically Ill Patients
Status: Enrolling
Updated:  11/16/2015
Va San Diego Health Care System
mi
from
San Diego, CA
Single Dose Enteral Tranexamic Acid in Critically Ill Patients
Single Dose Enteral Tranexamic Acid for the Reduction of Morbidity in Hospitalized Critically Ill Patients
Status: Enrolling
Updated: 11/16/2015
Va San Diego Health Care System
mi
from
San Diego, CA
Click here to add this to my saved trials
The CARRA Registry
The CARRA Registry
Status: Enrolling
Updated:  11/16/2015
Duke Clinical Research Institute
mi
from
Durham, NC
The CARRA Registry
The CARRA Registry
Status: Enrolling
Updated: 11/16/2015
Duke Clinical Research Institute
mi
from
Durham, NC
Click here to add this to my saved trials
Pilot Study: Cardiovascular Events in High Risk Orthopedic Surgical Patients
Pilot Study: Cardiovascular Events in High Risk Orthopedic Surgical Patients
Status: Enrolling
Updated:  11/16/2015
NYU Hospital for Joint Diseases
mi
from
New York, NY
Pilot Study: Cardiovascular Events in High Risk Orthopedic Surgical Patients
Pilot Study: Cardiovascular Events in High Risk Orthopedic Surgical Patients
Status: Enrolling
Updated: 11/16/2015
NYU Hospital for Joint Diseases
mi
from
New York, NY
Click here to add this to my saved trials
A Culturally Sensitive Values-Guided Aid for End of Life Decision-Making
A Culturally Sensitive Values-Guided Aid for End of Life Decision-Making
Status: Enrolling
Updated:  11/16/2015
Michael E. Debakey VA Medical Center
mi
from
Houston, TX
A Culturally Sensitive Values-Guided Aid for End of Life Decision-Making
A Culturally Sensitive Values-Guided Aid for End of Life Decision-Making
Status: Enrolling
Updated: 11/16/2015
Michael E. Debakey VA Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Serial BNP Testing for Heart Failure Management
Utilizing, Studying, Evaluating BNP for Monitoring in Patients With Heart Failure (USE-BNP)
Status: Enrolling
Updated:  11/16/2015
Palo Alto VA Health Care System
mi
from
Palo Alto, CA
Serial BNP Testing for Heart Failure Management
Utilizing, Studying, Evaluating BNP for Monitoring in Patients With Heart Failure (USE-BNP)
Status: Enrolling
Updated: 11/16/2015
Palo Alto VA Health Care System
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Serial BNP Testing for Heart Failure Management
Utilizing, Studying, Evaluating BNP for Monitoring in Patients With Heart Failure (USE-BNP)
Status: Enrolling
Updated:  11/16/2015
Bellevue Hospital
mi
from
New York City, NY
Serial BNP Testing for Heart Failure Management
Utilizing, Studying, Evaluating BNP for Monitoring in Patients With Heart Failure (USE-BNP)
Status: Enrolling
Updated: 11/16/2015
Bellevue Hospital
mi
from
New York City, NY
Click here to add this to my saved trials
Serial BNP Testing for Heart Failure Management
Utilizing, Studying, Evaluating BNP for Monitoring in Patients With Heart Failure (USE-BNP)
Status: Enrolling
Updated:  11/16/2015
Hudson Valley Heart Center
mi
from
Poughkeepsie, NY
Serial BNP Testing for Heart Failure Management
Utilizing, Studying, Evaluating BNP for Monitoring in Patients With Heart Failure (USE-BNP)
Status: Enrolling
Updated: 11/16/2015
Hudson Valley Heart Center
mi
from
Poughkeepsie, NY
Click here to add this to my saved trials
Serial BNP Testing for Heart Failure Management
Utilizing, Studying, Evaluating BNP for Monitoring in Patients With Heart Failure (USE-BNP)
Status: Enrolling
Updated:  11/16/2015
Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
Serial BNP Testing for Heart Failure Management
Utilizing, Studying, Evaluating BNP for Monitoring in Patients With Heart Failure (USE-BNP)
Status: Enrolling
Updated: 11/16/2015
Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Serial BNP Testing for Heart Failure Management
Utilizing, Studying, Evaluating BNP for Monitoring in Patients With Heart Failure (USE-BNP)
Status: Enrolling
Updated:  11/16/2015
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Serial BNP Testing for Heart Failure Management
Utilizing, Studying, Evaluating BNP for Monitoring in Patients With Heart Failure (USE-BNP)
Status: Enrolling
Updated: 11/16/2015
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Serial BNP Testing for Heart Failure Management
Utilizing, Studying, Evaluating BNP for Monitoring in Patients With Heart Failure (USE-BNP)
Status: Enrolling
Updated:  11/16/2015
Virginia Research Institute
mi
from
Danville, VA
Serial BNP Testing for Heart Failure Management
Utilizing, Studying, Evaluating BNP for Monitoring in Patients With Heart Failure (USE-BNP)
Status: Enrolling
Updated: 11/16/2015
Virginia Research Institute
mi
from
Danville, VA
Click here to add this to my saved trials
Serial BNP Testing for Heart Failure Management
Utilizing, Studying, Evaluating BNP for Monitoring in Patients With Heart Failure (USE-BNP)
Status: Enrolling
Updated:  11/16/2015
Centre Hospitalier Universitaire de Sherbrooke
mi
from
Fleurimont,
Serial BNP Testing for Heart Failure Management
Utilizing, Studying, Evaluating BNP for Monitoring in Patients With Heart Failure (USE-BNP)
Status: Enrolling
Updated: 11/16/2015
Centre Hospitalier Universitaire de Sherbrooke
mi
from
Fleurimont,
Click here to add this to my saved trials
Educating Nurses About Venous Thromboembolism (VTE) Prevention
Educating Nurses About Venous Thromboembolism Prevention
Status: Enrolling
Updated:  11/16/2015
Johns Hopkins Medical Institutions
mi
from
Baltimore, MD
Educating Nurses About Venous Thromboembolism (VTE) Prevention
Educating Nurses About Venous Thromboembolism Prevention
Status: Enrolling
Updated: 11/16/2015
Johns Hopkins Medical Institutions
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study to Evaluate the Effectiveness of Cardiac Rehabilitation (Rehab) for Acute Decompensated Heart Failure Patients on 6 Minute Walk Test and Quality of Life
Randomized, Single Center Study to Determine if a Cardiac Rehabilitation Program Immediately Following Hospitalization Reduces Hospital Readmissions and Improves Quality of Life Outcomes in Heart Failure Patients.
Status: Enrolling
Updated:  11/17/2015
Sanford Heart Hospital
mi
from
Sioux Falls, SD
Study to Evaluate the Effectiveness of Cardiac Rehabilitation (Rehab) for Acute Decompensated Heart Failure Patients on 6 Minute Walk Test and Quality of Life
Randomized, Single Center Study to Determine if a Cardiac Rehabilitation Program Immediately Following Hospitalization Reduces Hospital Readmissions and Improves Quality of Life Outcomes in Heart Failure Patients.
Status: Enrolling
Updated: 11/17/2015
Sanford Heart Hospital
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
An Open Label, Multicenter, Single Arm Study of Pasireotide LAR in Patients With Rate Tumors of Neuroendocrine Origin
Status: Enrolling
Updated:  11/18/2015
Cedars Sinai Medical Center The Pituitary Center (3)
mi
from
Los Angeles, CA
Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
An Open Label, Multicenter, Single Arm Study of Pasireotide LAR in Patients With Rate Tumors of Neuroendocrine Origin
Status: Enrolling
Updated: 11/18/2015
Cedars Sinai Medical Center The Pituitary Center (3)
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
An Open Label, Multicenter, Single Arm Study of Pasireotide LAR in Patients With Rate Tumors of Neuroendocrine Origin
Status: Enrolling
Updated:  11/18/2015
Cedars Sinai Medical Center Cedars Sinai 4
mi
from
Los Angeles, CA
Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
An Open Label, Multicenter, Single Arm Study of Pasireotide LAR in Patients With Rate Tumors of Neuroendocrine Origin
Status: Enrolling
Updated: 11/18/2015
Cedars Sinai Medical Center Cedars Sinai 4
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
An Open Label, Multicenter, Single Arm Study of Pasireotide LAR in Patients With Rate Tumors of Neuroendocrine Origin
Status: Enrolling
Updated:  11/18/2015
Stanford University Medical Center SC
mi
from
Stanford, CA
Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
An Open Label, Multicenter, Single Arm Study of Pasireotide LAR in Patients With Rate Tumors of Neuroendocrine Origin
Status: Enrolling
Updated: 11/18/2015
Stanford University Medical Center SC
mi
from
Stanford, CA
Click here to add this to my saved trials
Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
An Open Label, Multicenter, Single Arm Study of Pasireotide LAR in Patients With Rate Tumors of Neuroendocrine Origin
Status: Enrolling
Updated:  11/18/2015
Dana Farber Cancer Institute Deptof DanaFarberCancerInst(5)
mi
from
Boston, MA
Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
An Open Label, Multicenter, Single Arm Study of Pasireotide LAR in Patients With Rate Tumors of Neuroendocrine Origin
Status: Enrolling
Updated: 11/18/2015
Dana Farber Cancer Institute Deptof DanaFarberCancerInst(5)
mi
from
Boston, MA
Click here to add this to my saved trials
Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
An Open Label, Multicenter, Single Arm Study of Pasireotide LAR in Patients With Rate Tumors of Neuroendocrine Origin
Status: Enrolling
Updated:  11/18/2015
Mount Sinai School of Medicine Study Coordinator
mi
from
New York, NY
Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
An Open Label, Multicenter, Single Arm Study of Pasireotide LAR in Patients With Rate Tumors of Neuroendocrine Origin
Status: Enrolling
Updated: 11/18/2015
Mount Sinai School of Medicine Study Coordinator
mi
from
New York, NY
Click here to add this to my saved trials
Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
An Open Label, Multicenter, Single Arm Study of Pasireotide LAR in Patients With Rate Tumors of Neuroendocrine Origin
Status: Enrolling
Updated:  11/18/2015
Swedish Medical Center Dept.ofSwedishMedicalCtr.(2)
mi
from
Seattle, WA
Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
An Open Label, Multicenter, Single Arm Study of Pasireotide LAR in Patients With Rate Tumors of Neuroendocrine Origin
Status: Enrolling
Updated: 11/18/2015
Swedish Medical Center Dept.ofSwedishMedicalCtr.(2)
mi
from
Seattle, WA
Click here to add this to my saved trials
Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
An Open Label, Multicenter, Single Arm Study of Pasireotide LAR in Patients With Rate Tumors of Neuroendocrine Origin
Status: Enrolling
Updated:  11/18/2015
Novartis Investigative Site
mi
from
Buenos Aires,
Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
An Open Label, Multicenter, Single Arm Study of Pasireotide LAR in Patients With Rate Tumors of Neuroendocrine Origin
Status: Enrolling
Updated: 11/18/2015
Novartis Investigative Site
mi
from
Buenos Aires,
Click here to add this to my saved trials
CorMatrix ECM Study: To Identify Inflammatory Markers Following CABG With/Without ECM
CorMatrix ECM Study: To Identify Inflammatory Markers Following CABG With/Without CorMatrix's Extra Cellular Matrix (ECM)
Status: Enrolling
Updated:  11/19/2015
Inova Heart and Vascular Institute
mi
from
Falls Church, VA
CorMatrix ECM Study: To Identify Inflammatory Markers Following CABG With/Without ECM
CorMatrix ECM Study: To Identify Inflammatory Markers Following CABG With/Without CorMatrix's Extra Cellular Matrix (ECM)
Status: Enrolling
Updated: 11/19/2015
Inova Heart and Vascular Institute
mi
from
Falls Church, VA
Click here to add this to my saved trials
The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MRI) in the Presence of Pacemakers and Implantable Cardioverter Defibrillators (ICDs)
The MagnaSafe Registry: Determining the Risks of MRI in the Presence of Pacemakers and Implantable Cardioverter Defibrillators
Status: Enrolling
Updated:  11/20/2015
Providence St. Joseph Medical Center
mi
from
Burbank, CA
The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MRI) in the Presence of Pacemakers and Implantable Cardioverter Defibrillators (ICDs)
The MagnaSafe Registry: Determining the Risks of MRI in the Presence of Pacemakers and Implantable Cardioverter Defibrillators
Status: Enrolling
Updated: 11/20/2015
Providence St. Joseph Medical Center
mi
from
Burbank, CA
Click here to add this to my saved trials
The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MRI) in the Presence of Pacemakers and Implantable Cardioverter Defibrillators (ICDs)
The MagnaSafe Registry: Determining the Risks of MRI in the Presence of Pacemakers and Implantable Cardioverter Defibrillators
Status: Enrolling
Updated:  11/20/2015
Scripps Clinic/Green Hospital
mi
from
La Jolla, CA
The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MRI) in the Presence of Pacemakers and Implantable Cardioverter Defibrillators (ICDs)
The MagnaSafe Registry: Determining the Risks of MRI in the Presence of Pacemakers and Implantable Cardioverter Defibrillators
Status: Enrolling
Updated: 11/20/2015
Scripps Clinic/Green Hospital
mi
from
La Jolla, CA
Click here to add this to my saved trials
The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MRI) in the Presence of Pacemakers and Implantable Cardioverter Defibrillators (ICDs)
The MagnaSafe Registry: Determining the Risks of MRI in the Presence of Pacemakers and Implantable Cardioverter Defibrillators
Status: Enrolling
Updated:  11/20/2015
Scripps Memorial Hospital
mi
from
La Jolla, CA
The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MRI) in the Presence of Pacemakers and Implantable Cardioverter Defibrillators (ICDs)
The MagnaSafe Registry: Determining the Risks of MRI in the Presence of Pacemakers and Implantable Cardioverter Defibrillators
Status: Enrolling
Updated: 11/20/2015
Scripps Memorial Hospital
mi
from
La Jolla, CA
Click here to add this to my saved trials
The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MRI) in the Presence of Pacemakers and Implantable Cardioverter Defibrillators (ICDs)
The MagnaSafe Registry: Determining the Risks of MRI in the Presence of Pacemakers and Implantable Cardioverter Defibrillators
Status: Enrolling
Updated:  11/20/2015
UCLA Cardiac Arrhythmia Center
mi
from
Los Angeles, CA
The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MRI) in the Presence of Pacemakers and Implantable Cardioverter Defibrillators (ICDs)
The MagnaSafe Registry: Determining the Risks of MRI in the Presence of Pacemakers and Implantable Cardioverter Defibrillators
Status: Enrolling
Updated: 11/20/2015
UCLA Cardiac Arrhythmia Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MRI) in the Presence of Pacemakers and Implantable Cardioverter Defibrillators (ICDs)
The MagnaSafe Registry: Determining the Risks of MRI in the Presence of Pacemakers and Implantable Cardioverter Defibrillators
Status: Enrolling
Updated:  11/20/2015
Spectrum Clinical Research
mi
from
Moreno Valley, CA
The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MRI) in the Presence of Pacemakers and Implantable Cardioverter Defibrillators (ICDs)
The MagnaSafe Registry: Determining the Risks of MRI in the Presence of Pacemakers and Implantable Cardioverter Defibrillators
Status: Enrolling
Updated: 11/20/2015
Spectrum Clinical Research
mi
from
Moreno Valley, CA
Click here to add this to my saved trials
The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MRI) in the Presence of Pacemakers and Implantable Cardioverter Defibrillators (ICDs)
The MagnaSafe Registry: Determining the Risks of MRI in the Presence of Pacemakers and Implantable Cardioverter Defibrillators
Status: Enrolling
Updated:  11/20/2015
Yale University School of Medicine
mi
from
New Haven, CT
The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MRI) in the Presence of Pacemakers and Implantable Cardioverter Defibrillators (ICDs)
The MagnaSafe Registry: Determining the Risks of MRI in the Presence of Pacemakers and Implantable Cardioverter Defibrillators
Status: Enrolling
Updated: 11/20/2015
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MRI) in the Presence of Pacemakers and Implantable Cardioverter Defibrillators (ICDs)
The MagnaSafe Registry: Determining the Risks of MRI in the Presence of Pacemakers and Implantable Cardioverter Defibrillators
Status: Enrolling
Updated:  11/20/2015
Aventura Hospital and Medical Center
mi
from
Aventura, FL
The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MRI) in the Presence of Pacemakers and Implantable Cardioverter Defibrillators (ICDs)
The MagnaSafe Registry: Determining the Risks of MRI in the Presence of Pacemakers and Implantable Cardioverter Defibrillators
Status: Enrolling
Updated: 11/20/2015
Aventura Hospital and Medical Center
mi
from
Aventura, FL
Click here to add this to my saved trials
The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MRI) in the Presence of Pacemakers and Implantable Cardioverter Defibrillators (ICDs)
The MagnaSafe Registry: Determining the Risks of MRI in the Presence of Pacemakers and Implantable Cardioverter Defibrillators
Status: Enrolling
Updated:  11/20/2015
Northern Indiana Research Alliance
mi
from
Fort Wayne, IN
The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MRI) in the Presence of Pacemakers and Implantable Cardioverter Defibrillators (ICDs)
The MagnaSafe Registry: Determining the Risks of MRI in the Presence of Pacemakers and Implantable Cardioverter Defibrillators
Status: Enrolling
Updated: 11/20/2015
Northern Indiana Research Alliance
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MRI) in the Presence of Pacemakers and Implantable Cardioverter Defibrillators (ICDs)
The MagnaSafe Registry: Determining the Risks of MRI in the Presence of Pacemakers and Implantable Cardioverter Defibrillators
Status: Enrolling
Updated:  11/20/2015
Baptist Health Lexington
mi
from
Lexington, KY
The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MRI) in the Presence of Pacemakers and Implantable Cardioverter Defibrillators (ICDs)
The MagnaSafe Registry: Determining the Risks of MRI in the Presence of Pacemakers and Implantable Cardioverter Defibrillators
Status: Enrolling
Updated: 11/20/2015
Baptist Health Lexington
mi
from
Lexington, KY
Click here to add this to my saved trials
The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MRI) in the Presence of Pacemakers and Implantable Cardioverter Defibrillators (ICDs)
The MagnaSafe Registry: Determining the Risks of MRI in the Presence of Pacemakers and Implantable Cardioverter Defibrillators
Status: Enrolling
Updated:  11/20/2015
Providence Heart Institute
mi
from
Southfield, MI
The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MRI) in the Presence of Pacemakers and Implantable Cardioverter Defibrillators (ICDs)
The MagnaSafe Registry: Determining the Risks of MRI in the Presence of Pacemakers and Implantable Cardioverter Defibrillators
Status: Enrolling
Updated: 11/20/2015
Providence Heart Institute
mi
from
Southfield, MI
Click here to add this to my saved trials